Report of Foreign Issuer (6-k)
15 October 2018 - 11:20PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 OF
THE
SECURITIES EXCHANGE ACT OF 1934
For the month of, October 2018
Commission File Number 001-37652
Midatech
Pharma PLC
(Translation of registrant’s name
into English)
65 Innovation Drive
Milton Park
Abingdon, Oxfordshire, OX14 4RQ, United
Kingdom
(Address of principal executive offices)
Indicate by check mark whether the registrant
files or will file annual reports under cover of Form 20-F or Form 40-F:
Form 20-F
x
Form
40-F
o
Indicate by check mark if the registrant
is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
o
Indicate by check mark if the registrant
is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
o
SUBMITTED HEREWITH
Attached to the Registrant’s Form 6-K filing for the month
of October 2018, and incorporated by reference herein, is:
|
|
|
Exhibit No.
|
|
Description
|
|
|
99.1
|
|
Press release, dated October 15, 2018 entitled “Results of General Meeting.”
|
SIGNATURE
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.
|
|
|
|
|
|
|
|
|
|
|
|
|
Midatech Pharma PLC
|
|
|
|
|
Date: October 15, 2018
|
|
|
|
By:
|
|
/s/ Nicholas Robbins-Cherry
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nicholas Robbins-Cherry
Chief Financial Officer
|
Exhibit Index
|
|
|
Exhibit No.
|
|
Description
|
|
|
99.1
|
|
Press release, dated October 15, 2018 entitled “Results of General Meeting.”
|
Midatech Pharma (NASDAQ:MTP)
Historical Stock Chart
From Apr 2024 to May 2024
Midatech Pharma (NASDAQ:MTP)
Historical Stock Chart
From May 2023 to May 2024